Raymond James Trust’s Nuveen Core Equity Alpha Fund JCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$358K Hold
23,290
0.01% 945
2024
Q2
$349K Hold
23,290
0.01% 898
2024
Q1
$328K Sell
23,290
-4,000
-15% -$54.4K 0.01% 927
2023
Q4
$370K Hold
27,290
0.01% 823
2023
Q3
$339K Buy
27,290
+4,844
+22% +$61.9K 0.01% 813
2023
Q2
$286K Buy
22,446
+2,881
+15% +$35.4K 0.01% 915
2023
Q1
$241K Hold
19,565
0.01% 970
2022
Q4
$265K Hold
19,565
0.01% 893
2022
Q3
$237K Hold
19,565
0.01% 901
2022
Q2
$261K Buy
+19,565
New +$286K 0.01% 871
2021
Q1
Sell
-11,973
Closed -$168K 1115
2020
Q4
$168K Hold
11,973
0.01% 991
2020
Q3
$153K Hold
11,973
0.01% 916
2020
Q2
$146K Hold
11,973
0.01% 877
2020
Q1
$128K Hold
11,973
0.01% 760
2019
Q4
$175K Buy
+11,973
New +$173K 0.01% 899
2016
Q2
Sell
-10,165
Closed -$139K 687
2016
Q1
$139K Buy
+10,165
New +$134K 0.01% 623

Other funds holding JCE

Raymond James Trust's JCE Position: Q3 2024 in Review

Raymond James Trust held its Nuveen Core Equity Alpha Fund (JCE) position steady in Q3 2024 at 23,290 shares worth $358K. The position accounts for 0.01% of the portfolio, ranked #945.

Raymond James Trust first reported a position in JCE in Q1 2016 and has held it in 16 quarters since. The position peaked at $370K in Q4 2023. 48 funds tracked by Wall St. Rank hold JCE as of Q3 2024.

  • Raymond James Trust held 23,290 shares of Nuveen Core Equity Alpha Fund worth $358K as of Q3 2024.
  • Raymond James Trust left its Nuveen Core Equity Alpha Fund share count unchanged in Q3 2024.
  • Nuveen Core Equity Alpha Fund made up 0.01% of Raymond James Trust's portfolio in Q3 2024, its #945 holding.
  • Raymond James Trust first reported a position in Nuveen Core Equity Alpha Fund in Q1 2016 and has held it in 16 quarters since.
  • Raymond James Trust's Nuveen Core Equity Alpha Fund position peaked at $370K in Q4 2023.
  • 48 funds tracked by Wall St. Rank held Nuveen Core Equity Alpha Fund as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.